Eli Lilly

YTD

ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.

CEO

David A. Ricks

CEODavid A. Ricks

Employees

47,000

Employees47,000

Headquarters

Indianapolis, Indiana

HeadquartersIndianapolis, Indiana

Founded

1876

Founded1876

Employees

47,000

Employees47,000

LLY Key Statistics

Market cap

729.78B

Market cap729.78B

Price-Earnings ratio

63.78

Price-Earnings ratio63.78

Dividend yield

0.73%

Dividend yield0.73%

Average volume

3.31M

Average volume3.31M

High today

$772.58

High today$772.58

Low today

$765.20

Low today$765.20

Open price

$768.50

Open price$768.50

Volume

2.07M

Volume2.07M

52 Week high

$972.53

52 Week high$972.53

52 Week low

$677.09

52 Week low$677.09

LLY News

The Motley Fool 4d

Should You Invest $1,000 in Eli Lilly today?

Eli Lilly (LLY 2.13%) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. The pharma giant's presence across several...

The Motley Fool 5d

Prediction: Eli Lilly Will Reach a $1 Trillion Valuation by 2027

Eli Lilly (LLY 0.47%) has been a growth beast over the years and is now easily the most valuable healthcare company in the world, with a market cap of more than...

Simply Wall St 5d

Eli Lilly Advances Ovarian Cancer Treatment And Transfers Cialis Rights In Latin America

recently announced promising Phase 1 data for its folate receptor alpha antibody-drug conjugate, showcasing significant progress in oncology treatments for ovar...

Analyst ratings

84%

of 31 ratings

Buy

83.9%

Hold

9.7%

Sell

6.5%

More LLY News

The Motley Fool 7d

Could Viking Therapeutics Become the Next Eli Lilly?

The obesity treatment market is booming, with groundbreaking drugs like Eli Lilly's (LLY 2.28%) Zepbound delivering transformative patient results and powering...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Novo Nordisk

Broadcom

Costco

Taiwan Semiconductor Manu…

Meta Platforms

Microsoft